AI in Life Sciences: Balancing Risk and Innovation

Does generative AI have a place in the highly regulated world of life sciences, and can it produce value without compromising patient safety?

In this episode of the Talking AI podcast, host Matt Paige sits down with Matt Lewis, Global Chief AI Officer at Inizio Medical, to explore the delicate balance between innovation and risk in healthcare AI.

Matt brings a wealth of experience from his role at Inizio Medical, a powerhouse in the life sciences industry that balances scientific knowledge with cutting-edge technology like AI to transform medical communication and content.

He shares invaluable insights on how AI is transforming pharmaceutical research, biotech advancements, and medical device development.

Matt reveals Inizio’s strategy for prioritizing AI use cases, explaining why there's no one-size-fits-all approach in such a complex field. He also discusses how AI can save time in creating patient summaries and why personalization and custom AI tools are needed to produce complex content.
---
Key moments:
00:51 AI in Life Sciences: An Overview
03:34 Internal vs. External AI Responsibilities
12:26 Unique AI Use Cases in Life Sciences
16:59 RAG (Retrieval-Augmented Generation) in AI
18:24 The Future of AI Model Harmonization
24:34 AI in Patient Communication
32:58 Synthetic Media and AI-Powered Training
36:51 Keeping Up with AI Advancements
39:42 The Adoption of AI in the Mainstream
---
Key links:
---

#ArtificialIntelligence #AI #TalkingAI #Podcast

More from Talking AI ⬇️